Am I a Good Candidate for B-12 Injections
Food and Drug Administration has flagged BPC-157 among bulk substances reviewed for compounding, and long-term human safety has not been established
Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin
However, it is crucial to understand that BPC-157 is not approved for human use by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, the European Medicines Agency (EMA), or the US Food and Drug Administration (FDA)
It modulates neurotransmitter systems including dopamine and serotonin
For most people dealing with lower back pain, abdominal injections work perfectly well